SPRUCE BIOSCIENCES INC (SPRB)
US85209E1091 - Common Stock
ChartMill assigns a Buy % Consensus number of 75% to SPRB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.55. This target is 567.36% above the current price.
SPRB was analyzed by 13 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about SPRB.
In the previous month the buy percentage consensus was at a similar level.
SPRB was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-16 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-12-12 | Guggenheim | Reiterate | Neutral -> Neutral |
| 2024-12-11 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-12-11 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-12-11 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-12 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-08-19 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-13 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-06-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-06-05 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-03-14 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-03-14 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2024-03-14 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-03-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-03-14 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-03-14 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-03-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-21 | Guggenheim | Initiate | Buy |
| 2023-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-13 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2023-08-18 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-16 | JMP Securities | Maintains | Outperform -> Outperform |
| 2023-08-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-23 | Oppenheimer | Reiterate | Outperform -> Outperform |